Clinical Trial: Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thyroid Cancer
Study Type: INTERVENTIONAL
Official Title: Restoration of Radioiodine Uptake With Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: A Phase 2 Study Performed in Collaboration With the International Thyroid Oncology Gr
Brief Summary:
This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131) uptake and allow for I-131 treatment in people with RET fusion-positive radioiodine-refractory thyroid cancer.This research study involves the study drug selpercatinib in combination with standard of care treatments, I-131 and thyrotropin alfa (rhTSH).
Read more